🧪
hypothesis

Transglutaminase-2 Cross-Linking Inhibition Strategy

Hypothesis

Transglutaminase-2 Cross-Linking Inhibition Strategy

Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, and TDP-43, stabilizing heterologous aggregates.
🧬 TGM2🩺 neurodegeneration🎯 Composite 64%💱 $0.56▼24.3%proposed
🟡 ALS / Motor Neuron Disease🔴 Alzheimer's Disease🔮 Lysosomal / Autophagy🔥 Neuroinflammation
EvidencePending (0%)📖 9 cit🗣 3 debates 3 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.75 (15%) Evidence 0.60 (15%) Novelty 0.70 (12%) Feasibility 0.80 (12%) Impact 0.70 (12%) Druggability 0.85 (10%) Safety 0.65 (8%) Competition 0.75 (6%) Data Avail. 0.70 (5%) Reproducible 0.75 (5%) KG Connect 0.74 (8%) 0.639 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite64%

🧪 Overview

Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, and TDP-43, stabilizing heterologous aggregates. Selective TG2 inhibitors targeting the cross-seeding-specific substrate sites could disrupt mixed aggregate formation while preserving physiological TG2 functions.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

graph TD
    A["""Neuroinflammation<br/>&amp; Calcium Dysregulation"""] -->|"Ca2+ Influx"| B["TG2 Activation<br/>(Transglutaminase-2)"]

    B -->|"Isopeptide Bond<br/>Formation"| C["Tau Cross-Linking<br/>&amp; Aggregation"]
    B -->|"Protein Cross-Linking"| D["Abeta Oligomer<br/>Stabilization"]
    B -->|"ECM Cross-Linking"| E["BBB Disruption<br/>&amp; Matrix Stiffening"]
    B -->|"NF-kappaB Activation"| F["Pro-inflammatory<br/>Cytokine Cascade"]

    C --> G["Neurofibrillary<br/>Tangle Formation"]
    D --> H["Amyloid Plaque<br/>Stabilization"]
    E --> I["Peripheral Immune<br/>Cell Infiltration"]
    F --> J["Chronic<br/>Neuroinflammation"]

    G --> K["Neuronal Death<br/>&amp; Cognitive Decline"]
    H --> K
    I --> J
    J --> K

    L["""TG2 Inhibitor<br/>Therapy"""] -->|"Selective Active-Site<br/>Blockade"| M["TG2 Cross-Linking<br/>Inhibition"]
    M -->|"Reduced Tau<br/>Cross-Linking"| N["Prevented Tangle<br/>Formation"]
    M -->|"Reduced Abeta<br/>Stabilization"| O["Enhanced Abeta<br/>Clearance"]
    M -->|"Preserved BBB<br/>Integrity"| P["Reduced Immune<br/>Infiltration"]
    M -->|"Suppressed NF-kappaB"| Q["Reduced<br/>Neuroinflammation"]

    N --> R["Neuroprotection &amp;<br/>Cognitive Preservation"]
    O --> R
    P --> R
    Q --> R

    style A fill:#ff8a80,stroke:#d32f2f,color:#000
    style L fill:#4fc3f7,stroke:#2196f3,color:#000
    style R fill:#81c784,stroke:#4caf50,color:#000
    style K fill:#ffab91,stroke:#e64a19,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
Transglutaminase-2 cross-links tau, α-synuclein, and TDP-43 in disease conditions
PMID:25242045
Supports
TG2 activity is elevated in multiple neurodegenerative diseases
PMID:27784544
Supports
Selective TG2 inhibitors reduce protein aggregation
PMID:31756126
Contradicts
TG2 activity can be protective in some neurodegeneration contexts
PMID:27784544
Contradicts
TG2 cross-linking often occurs after aggregate formation, not during initial seeding
PMID:25242045
Contradicts
Non-selective TG2 inhibition causes significant toxicity
PMID:28847752
📖 Linked Papers (9)Export BibTeX ↗
The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases.
International journal of molecular sciences (2024) · PubMed:39769187 ↗
4 figures
Figure 1
Figure 1
Toxic protein biomarkers shared by specific and mixed pathology NDDs. The references supporting these relationships are cited in the main body of the text. The ...
Figure 2
Figure 2
Calcium–calmodulin mediated signal transduction in normal neurons ( top panel ) and neurodegeneration ( lower panel ). This essential signaling pathway mediates...
[WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective and acute traumatological Hand Surgery Procedures].
Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... (2022) · PubMed:35168268 ↗
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
Successful Nonoperative Treatment of Osteochondritis Dissecans of the Humeral Capitellum in a Young Baseball Player with Advanced Skeletal Maturity.
Progress in rehabilitation medicine (2021) · PubMed:34825100 ↗
4 figures
Fig. 1.
Fig. 1.
Sonographic image of OCD of the humeral capitellum in the sagittal plane showing irregularity and discontinuity of the subchondral bone.
Fig. 2.
Fig. 2.
(A) Radiograph taken at the first examination showing an osteochondral lesion on the lateral side of the capitellum and new bone formation along the lateral sid...
Engineering complex communities by directed evolution.
Nature ecology & evolution (2021) · PubMed:33986540 ↗
9 figures
Extended Data Figure 1.
Extended Data Figure 1.
Non-additive function, costly function, and two empirically motivated functions. (A) Illustration of the different types of community function we have considere...
Extended Data Figure 2.
Extended Data Figure 2.
Alternative ecological scenarios with metabolic cross-feeding. Besides the rich medium without cross-feeding shown in the main text, we have included two other ...
Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.
International journal of molecular sciences (2020) · PubMed:32751379 ↗
3 figures
Figure 1
Figure 1
Occludin (OCLN) protein expression is significantly decreased in duodenal epithelium of celiac macaques. All panels involve triple labels with OCLN ( green ), c...
Figure 2
Figure 2
Immunopathology of central nervous system (CNS) disease in celiac disease patients and potential beneficial (treatment) role of phytocannabinoids as nutraceutic...
TGM2 and implications for human disease: role of alternative splicing.
Front Biosci (Landmark Ed) (2013) · PubMed:23276939 ↗
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
Transglutaminase 2 modulates inflammatory angiogenesis via vascular endothelial growth factor receptor 2 pathway in inflammatory bowel disease.
J Adv Res (2026) · PubMed:40619121 ↗
No figures
Calmodulin Binding Domains in Critical Risk Proteins Involved in Neurodegeneration.
Current issues in molecular biology (2022) · PubMed:36421678 ↗
No figures
Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.
Cell Death Differ (2021) · PubMed:32704090 ↗
No figures
📙 Related Wiki Pages (15)
EEDgeneNeurodegenerationdiseaseAlibaba Tongyi Qianwen-Bio (Chinese Biomai_toolTGM2 ProteinproteinTGM2 — Transglutaminase 2geneAmyotrophic Lateral SclerosisredirectTau OligomersentityGenesindexEndoplasmic Reticulum Stress and UnfoldemechanismDopaminergic NeuronscellBlood-Brain BarriercellParkinson's DiseasediseaseAmyotrophic Lateral Sclerosis (ALS)diseaseAlzheimer's DiseasediseaseHuntington's Diseasedisease

🏥 Translation

🧬 3D Protein Structure — TGM2

No curated PDB or AlphaFold mapping for TGM2 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for TGM2 from GTEx v10.

Spinal cord cervical c-130.5 Substantia nigra26.5 Cortex26.4 Caudate basal ganglia17.4 Putamen basal ganglia17.2 Hypothalamus16.8 Cerebellum16.3 Frontal Cortex BA915.3 Hippocampus15.2 Nucleus accumbens basal ganglia13.4 Anterior cingulate cortex BA2411.5 Amygdala11.4 Cerebellar Hemisphere8.4median TPM (GTEx v10)

💉 Clinical Trials (4)Relevance: 13%

2
Active
2
Completed
0
Total Enrolled
Phase II/III
Highest Phase
Cysteamine Bitartrate in Huntington's Disease (CYST-HD)Phase II/III
Completed·NCT02101957
Cysteamine for Neurodegenerative DiseasePhase II
Completed·NCT03344601
Zampilimab (anti-TG2) in Celiac DiseasePhase II
Recruiting·NCT04870866
Cross-Seeding Biomarkers in Neurodegenerative DiseaseObservational
Recruiting·NCT05538455

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TGM2 →

No DepMap CRISPR Chronos data found for TGM2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
2.0 years

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.4%
Volatility
Medium
0.0222
Events (7d)
4
Price History
▼24.3%

💾 Resource Usage

LLM Tokens
36,356
$0.2181
Total Cost
$0.2181

🔮 Predictions

🔎 Predictions vs Observations3 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If hypothesis is true, intervention provide non-invasive measures of enzyme activity and inhibitor penetrationprovide non-invasive measures of enzyme activity and inhibitor penetration— no observation —pending0.60
If hypothesis is true, intervention be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementiabe most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia— no observation —pending0.60
If hypothesis is true, intervention enable non-invasive monitoring of enzyme activity in living brainsenable non-invasive monitoring of enzyme activity in living brains— no observation —pending0.60
🔮 Falsifiable Predictions (3)
pendingconf 60%
If hypothesis is true, intervention be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
Predicted outcome: be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
Falsification: Intervention fails to be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
pendingconf 60%
If hypothesis is true, intervention enable non-invasive monitoring of enzyme activity in living brains
Predicted outcome: enable non-invasive monitoring of enzyme activity in living brains
Falsification: Intervention fails to enable non-invasive monitoring of enzyme activity in living brains
pendingconf 60%
If hypothesis is true, intervention provide non-invasive measures of enzyme activity and inhibitor penetration
Predicted outcome: provide non-invasive measures of enzyme activity and inhibitor penetration
Falsification: Intervention fails to provide non-invasive measures of enzyme activity and inhibitor penetration
View on SciDEX ↗